137 related articles for article (PubMed ID: 26762631)
1. Prognosis After Brain Metastasis from Differentiated Thyroid Carcinoma.
Saito F; Uruno T; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
World J Surg; 2016 Mar; 40(3):574-81. PubMed ID: 26762631
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
Osborne JR; Kondraciuk JD; Rice SL; Zhou X; Knezevic A; Spratt DE; Sabra M; Larson SM; Grewal RK
Clin Nucl Med; 2019 Jul; 44(7):544-549. PubMed ID: 31107749
[TBL] [Abstract][Full Text] [Related]
3. The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
Choi J; Kim JW; Keum YS; Lee IJ
PLoS One; 2016; 11(4):e0154739. PubMed ID: 27128487
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases from thyroid carcinoma: a retrospective study of 21 patients.
Henriques de Figueiredo B; Godbert Y; Soubeyran I; Carrat X; Lagarde P; Cazeau AL; Italiano A; Sargos P; Kantor G; Loiseau H; Bonichon F
Thyroid; 2014 Feb; 24(2):270-6. PubMed ID: 23734630
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome after bone metastasis (BM) surgery in patients with differentiated thyroid carcinoma (DTC): a retrospective study of 40 cases.
Nakayama R; Horiuchi K; Susa M; Watanabe I; Watanabe K; Tsuji T; Matsumoto M; Toyama Y; Morioka H
Jpn J Clin Oncol; 2014 Oct; 44(10):918-25. PubMed ID: 25104791
[TBL] [Abstract][Full Text] [Related]
6. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
Lee J; Soh EY
Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
[TBL] [Abstract][Full Text] [Related]
7. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis.
Miller D; Zappala V; El Hindy N; Livingstone E; Schadendorf D; Sure U; Sandalcioglu IE
Clin Neurol Neurosurg; 2013 Sep; 115(9):1721-8. PubMed ID: 23643143
[TBL] [Abstract][Full Text] [Related]
10. Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection.
Antuña AR; Vega MA; Sanchez CR; Fernandez VM
J Neurol Surg A Cent Eur Neurosurg; 2018 Mar; 79(2):101-107. PubMed ID: 28586934
[TBL] [Abstract][Full Text] [Related]
11. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
[TBL] [Abstract][Full Text] [Related]
12. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and follow-up of intracranial metastases from thyroid cancer.
Lee HS; Yoo H; Lee SH; Gwak HS; Shin SH
Acta Neurochir (Wien); 2015 Dec; 157(12):2185-94. PubMed ID: 26476828
[TBL] [Abstract][Full Text] [Related]
14. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas.
Bernier MO; Leenhardt L; Hoang C; Aurengo A; Mary JY; Menegaux F; Enkaoua E; Turpin G; Chiras J; Saillant G; Hejblum G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1568-73. PubMed ID: 11297585
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
Kondraciuk JD; Rice SL; Zhou X; Gharzeddine K; Knezevic A; Spratt DE; Sabra M; Larson SM; Grewal RK; Osborne JR
Clin Nucl Med; 2019 Aug; 44(8):e465-e471. PubMed ID: 31274625
[TBL] [Abstract][Full Text] [Related]
16. Brain metastasis from renal cell carcinoma.
Bennani O; Derrey S; Langlois O; Castel H; Laquerriere A; Freger P; Proust F
Neurochirurgie; 2014; 60(1-2):12-6. PubMed ID: 24636403
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas.
Wassermann J; Bernier MO; Spano JP; Lepoutre-Lussey C; Buffet C; Simon JM; Ménégaux F; Tissier F; Leban M; Leenhardt L
Oncologist; 2016 Jan; 21(1):50-8. PubMed ID: 26675742
[TBL] [Abstract][Full Text] [Related]
18. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
19. [Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors in 31 cases].
Zhang RL; Zhang H; Zhang L; Xiao L; Sun YN; Yang Y; Bao YX
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):305-9. PubMed ID: 27087379
[TBL] [Abstract][Full Text] [Related]
20. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]